Ventricular arrhythmias during pulmonary artery catheterization in the intensive care unit.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 4050827)

Published in Am J Med on October 01, 1985

Authors

C L Sprung, E H Marcial, R M Schein

Articles by these authors

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest (1992) 47.46

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med (1998) 13.94

Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med (1995) 10.29

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med (1991) 9.99

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med (1996) 5.25

A look into the nature and causes of human errors in the intensive care unit. Crit Care Med (1995) 5.14

Clinical antecedents to in-hospital cardiopulmonary arrest. Chest (1990) 4.94

The ACCP-SCCM consensus conference on sepsis and organ failure. Chest (1992) 4.35

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA (1991) 3.25

Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care Medicine. Crit Care Med (1995) 3.19

Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA (1997) 3.11

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med (1993) 2.84

Definitions for sepsis and organ failure. Crit Care Med (1992) 2.69

Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM). Intensive Care Med (2012) 2.49

A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med (1995) 2.48

The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med (1984) 2.37

Plasma cortisol levels in patients with septic shock. Crit Care Med (1990) 2.33

High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med (1987) 2.32

Evaluation of Institutional Review Board review and informed consent in publications of human research in critical care medicine. Crit Care Med (1998) 2.14

Recommendations for end-of-life care in the intensive care unit: The Ethics Committee of the Society of Critical Care Medicine. Crit Care Med (2001) 2.12

Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med (1990) 2.04

How to use an article on therapy or prevention: pneumonia prevention using subglottic secretion drainage. Crit Care Med (1997) 2.03

Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels. J Infect Dis (1992) 1.73

Application of SOFA score to trauma patients. Sequential Organ Failure Assessment. Intensive Care Med (1999) 1.66

Risk of right bundle-branch block and complete heart block during pulmonary artery catheterization. Crit Care Med (1989) 1.62

The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA (1996) 1.53

Living related donation in lung transplantation. Ethical considerations. Arch Intern Med (1995) 1.53

Pulmonary artery catheterization. Can there be an integrated strategy for guideline development and research promotion? JAMA (1993) 1.51

Why have new effective therapies for sepsis not been developed? Crit Care Med (1994) 1.50

Fulminant hepatic failure from a sea anemone sting. Ann Intern Med (1994) 1.43

Blast lung injury from an explosion on a civilian bus. Chest (1999) 1.42

Prior healthcare utilization as a predictor of survival for medical intensive care unit patients. Crit Care Med (2000) 1.42

HA-1A in septic patients with ARDS: results from the pivotal trial. Intensive Care Med (1994) 1.40

Acquired immunodeficiency syndrome and critical care. Crit Care Med (1990) 1.39

Definition of sepsis. Intensive Care Med (2001) 1.34

A look into the nature and causes of human errors in the intensive care unit. 1995. Qual Saf Health Care (2003) 1.31

ICU survival of patients with the acquired immunodeficiency syndrome. Crit Care Med (1986) 1.24

Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group. J Infect Dis (1996) 1.21

Holy consent--a dilemma for medical staff when maternal consent is withheld for emergency caesarean section. Int J Obstet Anesth (2006) 1.07

Hemodynamic alterations of heat stroke in the elderly. Chest (1979) 1.03

Evidence for increased permeability in reexpansion pulmonary edema. Am J Med (1981) 1.03

Is the physician's duty to the individual patient or to society? Crit Care Med (1995) 1.02

The impact of regional culture on intensive care end of life decision making: an Israeli perspective from the ETHICUS study. J Med Ethics (2006) 1.02

Ventricular arrhythmias during Swan-Ganz catheterization of the critically ill. Chest (1981) 1.01

Spontaneous intracerebral hemorrhage in critically ill patients: incidence over six years and associated factors. Intensive Care Med (1999) 0.99

Relation of colloid osmotic pressure to arterial hypoxemia and cerebral edema during crystalloid volume loading of patients with diabetic ketoacidosis. Ann Intern Med (1982) 0.98

Foregoing life-sustaining treatment in an Israeli ICU. Intensive Care Med (1998) 0.96

The process of intensive care triage. Intensive Care Med (2001) 0.96

Effects of histamine on bronchial artery blood flow and bronchomotor tone. J Appl Physiol (1985) (1985) 0.95

The spectrum of pulmonary edema: differentiation of cardiogenic, intermediate, and noncardiogenic forms of pulmonary edema. Am Rev Respir Dis (1981) 0.94

Pulmonary edema; a complication of diabetic ketoacidosis. Chest (1980) 0.93

Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the Corticus study. Intensive Care Med (2011) 0.93

Complement activation and corticosteroid therapy in the development of the adult respiratory distress syndrome. Chest (1987) 0.90

Distribution of proteins in pulmonary edema. The value of fractional concentrations. Am Rev Respir Dis (1987) 0.89

Heat stroke; modern approach to an ancient disease. Chest (1980) 0.89

Amino acid alterations and encephalopathy in the sepsis syndrome. Crit Care Med (1991) 0.88

New technologies, critical care, and economic realities. Crit Care Med (1993) 0.88

End-of-life decision making in the intensive care unit. Intensive Care Med (2000) 0.88

Traumatic macroglossia: a life-threatening complication. Crit Care Med (1999) 0.88

Idiopathic capillary leak syndrome complicated by massive rhabdomyolysis. Chest (1993) 0.88

Corticosteroids in septic shock: resurrection of the last rites? Crit Care Med (1998) 0.87

Worldwide similarities and differences in the foregoing of life-sustaining treatments. Intensive Care Med (1996) 0.87

The metabolic and respiratory alterations of heat stroke. Arch Intern Med (1980) 0.87

Secondary bacterial peritonitis in cirrhotic patients with ascites. South Med J (1984) 0.86

New therapeutic approaches in sepsis: a critical review. Intensive Care Med (1995) 0.85

Definitions of sepsis--have we reached a consensus? Crit Care Med (1991) 0.84

Complement activation in septic shock patients. Crit Care Med (1986) 0.84

Increased risk of bloodstream and urinary infections in intensive care unit (ICU) patients compared with patients fitting ICU admission criteria treated in regular wards. J Hosp Infect (2005) 0.83

Triage decisions for intensive care in terminally ill patients. Intensive Care Med (1997) 0.82

Uremia in sickle-cell anemia treated by maintenance hemodialysis. N Engl J Med (1974) 0.81

High rate of candidemia in patients sustaining injuries in a bomb blast at a marketplace: a possible environmental source. Clin Infect Dis (2000) 0.81

Systolic pressure variation in hemodynamic monitoring after severe blast injury. J Clin Anesth (1999) 0.80

Raising the standard of hemodynamic monitoring: targeting the practice or the practitioner? Crit Care Med (1997) 0.79

Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation. Liver Transpl (2001) 0.79

Unilateral pulmonary edema after intubation of the right mainstem bronchus. Crit Care Med (1989) 0.78

The Swan-Ganz catheter. Twenty-five years of monitoring. Crit Care Clin (1996) 0.78

Advanced ventricular arrhythmias during bedside pulmonary artery catheterization. Am J Med (1982) 0.78

Practice parameters for sustained neuromuscular blockade in the adult critically ill patient: an executive summary. Society of Critical Care Medicine. Crit Care Med (1995) 0.78

Fulminant neuropathy and lactic acidosis associated with nucleoside analog therapy. Neurology (1999) 0.78

Pa catheterization--quo vadis? Do we have to change the current practice with this monitoring device? Intensive Care Med (1997) 0.78

Cost containment: the Middle East. Israel. New Horiz (1994) 0.78

Measurement of complement proteins C2 and B in systemic lupus erythematosus and septic shock. Complement Inflamm (1989) 0.78

Cross-cultural ethical decision-making in critical care. Crit Care Med (1998) 0.77

Comparison of measured and calculated colloid osmotic pressure of serum and pulmonary edema fluid in patients with pulmonary edema. Crit Care Med (1980) 0.77

A plea for caution in the performance of sepsis trials. Intensive Care Med (1995) 0.77

Modification of bronchial blood flow during allergic airway responses. J Appl Physiol (1985) (1988) 0.76

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest (2009) 0.76

Corticosteroids, nonsteroidal anti-inflammatory drugs, and naloxone in the sepsis syndrome. World J Surg (1987) 0.76

Pulmonary artery catheterization--at the crossroads? Crit Care Med (1994) 0.76

A calcified adenocarcinoma of the lung with very high CT numbers. Radiology (1984) 0.76

Effect of haemofiltration on pathological fibrinolysis due to severe sepsis: a case report. Resuscitation (1999) 0.76

Critical care education in the medical school curriculum. Crit Care Med (1999) 0.75